VEGFA and neovascular glaucoma: Combined with the literature and our results, preoperative anti-VEGF treatment of diabetic vitreous hemorrhage could reduce the chance of POVCH, lessen the chance of re-vitrectomy, and reduce the incidence of neovascular glaucoma.